Green Cross Holdings
KRX:005250
Green Cross Holdings
KRX:005250
Price:
13 980
KRW
1.45%
Market Closed
Market Cap:
₩669.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Green Cross Holdings
KRX:005250
|
KR |
|
S
|
SMC Global Securities Ltd
NSE:SMCGLOBAL
|
IN |
|
C
|
Cognizant Technology Solutions Corp
SWB:COZ
|
US |
|
Highpeak Energy Inc
NASDAQ:HPK
|
US |
|
Loomis AB
STO:LOOMIS
|
SE |
Relative Value
The Relative Value of one
Green Cross Holdings
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 13 980 KRW,
Green Cross Holdings
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Green Cross Holdings Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Green Cross Holdings Competitors
Green Cross Holdings Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Green Cross Holdings
KRX:005250
|
634.7B KRW | 0.3 | 4.9 | 13.6 | 93.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.2 | 14.3 | 19.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 19.9 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.1 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 10.9 | 129.2 | 72.2 | 80.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
